Caption Management, LLC Aurinia Pharmaceuticals Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.32 - $7.33 $159,600 - $219,900	30,000 Added 50.0%	90,000 $659,000
Q2 2024 Aug 14, 2024	BUY	$4.81 - $5.78 $288,600 - $346,800	60,000 New	60,000 $342,000
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $1.22 Million - $1.63 Million	171,600 Added 146.04%	289,100 $2.6 Million
Q3 2023 Nov 14, 2023	BUY	$7.77 - $12.27 $524,475 - $828,225	67,500 Added 135.0%	117,500 $912,000
Q2 2023 Aug 14, 2023	SELL	$8.96 - $11.69 $896,000 - $1.17 Million	-100,000 Reduced 66.67%	50,000 $484,000
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $504,900 - $957,950	85,000 Added 130.77%	150,000 $1.64 Million
Q4 2022 Feb 14, 2023	SELL	$4.11 - $8.14 $102,750 - $203,500	-25,000 Reduced 27.78%	65,000 $280,000
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $66,600 - $123,900	10,000 Added 12.5%	90,000 $676,000
Q1 2022 May 13, 2022	SELL	$10.05 - $22.48 $1.3 Million - $2.9 Million	-129,100 Reduced 61.74%	80,000 $990,000
Q4 2021 Feb 11, 2022	BUY	$17.78 - $33.08 $2.18 Million - $4.05 Million	122,500 Added 141.45%	209,100 $4.78 Million
Q3 2021 Nov 12, 2021	SELL	$10.93 - $23.55 $802,262 - $1.73 Million	-73,400 Reduced 45.88%	86,600 $1.92 Million
Q2 2021 Aug 16, 2021	BUY	$10.0 - $14.52 $400,000 - $580,800	40,000 Added 33.33%	160,000 $2.07 Million
Q1 2021 May 17, 2021	SELL	$12.3 - $18.73 $4.64 Million - $7.06 Million	-377,200 Reduced 75.86%	120,000 $1.56 Million
Q4 2020 Feb 16, 2021	BUY	$12.94 - $16.05 $443,842 - $550,515	34,300 Added 7.41%	497,200 $6.88 Million
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $2.59 Million - $3.27 Million	196,000 Added 73.44%	462,900 $6.82 Million
Q2 2020 Aug 14, 2020	SELL	$14.12 - $18.33 $155,320 - $201,629	-11,000 Reduced 3.96%	266,900 $4.34 Million
Q1 2020 May 15, 2020	SELL	$11.34 - $21.46 $3.08 Million - $5.83 Million	-271,700 Reduced 49.44%	277,900 $4.03 Million
Q4 2019 Feb 13, 2020	BUY	$3.88 - $21.42 $772,120 - $4.26 Million	199,000 Added 56.76%	549,600 $11.1 Million
Q3 2019 Nov 14, 2019	BUY	$5.34 - $6.59 $804,204 - $992,454	150,600 Added 75.3%	350,600 $1.87 Million
Q2 2019 Aug 13, 2019	BUY	$6.05 - $6.75 $302,500 - $337,500	50,000 Added 33.33%	200,000 $1.32 Million
Q1 2019 May 14, 2019	BUY	$6.06 - $7.64 $908,999 - $1.15 Million	150,000 New	150,000 $974,000

Others Institutions Holding AUPH

# of Institutions

207

Shares Held

58.6M

Call Options Held

1.14M

Put Options Held

1.51M

Black Rock Inc. New York, NY

9.27M
Shares

$83.7 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

8.2M
Shares

$74 Million
1.0% of portfolio
Tang Capital Management LLC San Diego, CA

7.23M
Shares

$65.3 Million
4.52% of portfolio
Nea Management Company, LLC Timonium, MD

3.97M
Shares

$35.8 Million
2.22% of portfolio
State Street Corp Boston, MA

2.95M
Shares

$26.6 Million
0.0% of portfolio

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.28B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account